{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T02:26:55Z","timestamp":1770431215178,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1038\/sj.ijo.0802887","type":"journal-article","created":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T10:27:16Z","timestamp":1107253636000},"page":"509-516","source":"Crossref","is-referenced-by-count":75,"title":["Influence of Sibutramine on blood pressure: evidence from placebo-controlled trials"],"prefix":"10.1038","volume":"29","author":[{"given":"J","family":"Jordan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Scholze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Matiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Hauner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A M","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,2,1]]},"reference":[{"key":"BF0802887_CR1","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1753-4887.1998.tb01722.x","volume":"56","author":"BM Popkin","year":"1998","unstructured":"Popkin BM, Doak CM . The obesity epidemic is a worldwide phenomenon. Nutr Rev 1998; 56: 106\u2013114.","journal-title":"Nutr Rev"},{"key":"BF0802887_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1001\/jama.1994.03520030047027","volume":"272","author":"RJ Kuczmarski","year":"1994","unstructured":"Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL . Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA 1994; 272: 205\u2013211.","journal-title":"JAMA"},{"key":"BF0802887_CR3","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1001\/jama.289.1.76","volume":"289","author":"AH Mokdad","year":"2003","unstructured":"Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS . Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289: 76\u201379.","journal-title":"JAMA"},{"key":"BF0802887_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/0003-4819-134-1-200101020-00007","volume":"134","author":"VJ Stevens","year":"2001","unstructured":"Stevens VJ, Obarzanek E, Cook NR, Lee IM, Appel LJ, Smith-West D, Milas NC, Mattfeldt-Beman M, Belden L, Bragg C, Millstone M, Raczynski J, Brewer A, Singh B, Cohen J . Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II. Ann Intern Med 2001; 134: 1\u201311.","journal-title":"Ann Intern Med"},{"key":"BF0802887_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/j.1550-8528.1999.tb00701.x","volume":"7","author":"GA Bray","year":"1999","unstructured":"Bray GA, Blackburn GL, Ferguson JM, Greenway FL, Jain AK, Mendel CM, Mendels J, Ryan DH, Schwartz SL, Scheinbaum ML, Seaton TB . Sibutramine produces dose-related weight loss. Obes Res 1999; 7: 189\u2013198.","journal-title":"Obes Res"},{"key":"BF0802887_CR6","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/S0140-6736(00)03491-7","volume":"356","author":"WP James","year":"2000","unstructured":"James WP, Astrup A, Finer N, Hilsted J, Kopelman P, Rossner S, Saris WH, Van-Gaal LF . Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance. Lancet 2000; 356: 2119\u20132125.","journal-title":"Lancet"},{"key":"BF0802887_CR7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0014-2999(02)01423-1","volume":"440","author":"CA Luque","year":"2002","unstructured":"Luque CA, Rey JA . The discovery and status of sibutramine as an anti-obesity drug. Eur J Pharmacol 2002; 440: 119\u2013128.","journal-title":"Eur J Pharmacol"},{"key":"BF0802887_CR8","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/sj.ijo.0801045","volume":"23","author":"KM Walsh","year":"1999","unstructured":"Walsh KM, Leen E, Lean ME . The effect of sibutramine on resting energy expenditure and adrenaline-induced thermogenesis in obese females. Int J Obes Relat Metab Disord 1999; 23: 1009\u20131015.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF0802887_CR9","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/j.1748-1716.1984.tb07546.x","volume":"122","author":"T Kahan","year":"1984","unstructured":"Kahan T, Hjemdahl P, Dahlof C . Relationship between the overflow of endogenous and radiolabelled noradrenaline from canine blood perfused gracilis muscle. Acta Physiol Scand 1984; 122: 571\u2013582.","journal-title":"Acta Physiol Scand"},{"key":"BF0802887_CR10","doi-asserted-by":"publisher","first-page":"R824","DOI":"10.1152\/ajpcell.1991.260.4.C824","volume":"260","author":"G Eisenhofer","year":"1991","unstructured":"Eisenhofer G, Saigusa T, Esler MD, Cox HS, Angus JA, Dorward PK . Central sympathoinhibition and peripheral neuronal uptake blockade after desipramine in rabbits. Am J Physiol 1991; 260: R824\u2013R832.","journal-title":"Am J Physiol"},{"key":"BF0802887_CR11","first-page":"R817","volume":"260","author":"MD Esler","year":"1991","unstructured":"Esler MD, Wallin G, Dorward PK, Eisenhofer G, Westerman R, Meredith I, Lambert G, Cox HS, Jennings G . Effects of desipramine on sympathetic nerve firing and norepinephrine spillover to plasma in humans. Am J Physiol 1991; 260: R817\u2013R823.","journal-title":"Am J Physiol"},{"key":"BF0802887_CR12","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1161\/01.CIR.0000036370.31856.73","volume":"106","author":"AL Birkenfeld","year":"2002","unstructured":"Birkenfeld AL, Schroeder C, Boschmann M, Tank J, Franke G, Luft FC, Biaggioni I, Sharma AM, Jordan J . Paradoxical effect of sibutramine on autonomic cardiovascular regulation. Circulation 2002; 106: 2459\u20132465.","journal-title":"Circulation"},{"key":"BF0802887_CR13","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1161\/hc0302.102597","volume":"105","author":"C Schroeder","year":"2002","unstructured":"Schroeder C, Tank J, Boschmann M, Diedrich A, Sharma AM, Biaggioni I, Luft FC, Jordan J . Selective norepinephrine reuptake inhibition as a human model of orthostatic intolerance. Circulation 2002; 105: 347\u2013353.","journal-title":"Circulation"},{"key":"BF0802887_CR14","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1161\/01.CIR.0000072786.99163.FE","volume":"107","author":"J Tank","year":"2003","unstructured":"Tank J, Schroeder C, Diedrich A, Szczech E, Haertter S, Sharma AM, Luft FC, Jordan J . Selective impairment in sympathetic vasomotor control with norepinephrine transporter inhibition. Circulation 2003; 107: 2949\u20132954.","journal-title":"Circulation"},{"key":"BF0802887_CR15","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1161\/01.HYP.25.4.560","volume":"25","author":"G Grassi","year":"1995","unstructured":"Grassi G, Seravalle G, Cattaneo BM, Bolla GB, Lanfranchi A, Colombo M, Giannattasio C, Brunani A, Cavagnini F, Mancia G . Sympathetic activation in obese normotensive subjects. Hypertension 1995; 25: 560\u2013563.","journal-title":"Hypertension"},{"key":"BF0802887_CR16","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1055\/s-2002-22671","volume":"127","author":"J Scholze","year":"2002","unstructured":"Scholze J . Adipositasbehandlung mit Sibutramin unter Praxisbedingungen. Deutsche Medizinische Wochenschrift 2002; 127: 606\u2013610.","journal-title":"Deutsche Medizinische Wochenschrift"},{"key":"BF0802887_CR17","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1001\/jama.286.11.1331","volume":"286","author":"A Wirth","year":"2001","unstructured":"Wirth A, Krause J . Long-term weight loss with sibutramine: a randomized controlled trial. JAMA 2001; 286: 1331\u20131339.","journal-title":"JAMA"},{"key":"BF0802887_CR18","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1055\/s-2004-817934","volume":"112","author":"H Hauner","year":"2004","unstructured":"Hauner H, Meier M, Wendland G, Kurscheid T, Lauterbach K, Study Group. Weight reduction by sibutramine in obese subjects in primary care medicine: the SAT Study. Exp Clin Endocrinol Diabetes 2004; 112: 201\u2013207.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"BF0802887_CR19","doi-asserted-by":"crossref","unstructured":"2003 European Society of Hypertension\u2013European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011\u20131053.","DOI":"10.1097\/00004872-200306000-00001"},{"key":"BF0802887_CR20","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1002\/sim.4780101105","volume":"10","author":"A Whitehead","year":"1991","unstructured":"Whitehead A, Whitehead J . A general parametric approach to the meta-analysis of randomized clinical trials. Stat Med 1991; 10: 1665\u20131677.","journal-title":"Stat Med"},{"key":"BF0802887_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/oby.2000.10","volume":"8","author":"GE Cuellar","year":"2000","unstructured":"Cuellar GE, Ruiz AM, Monsalve MC, Berber A . Six-month treatment of obesity with sibutramine 15\u2009mg; a double-blind, placebo-controlled monocenter clinical trial in a Hispanic population. Obes Res 2000; 8: 71\u201382.","journal-title":"Obes Res"},{"key":"BF0802887_CR22","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/sj.ijo.0801098","volume":"24","author":"G Fanghanel","year":"2000","unstructured":"Fanghanel G, Cortinas L, Sanchez-Reyes L, Berber A . A clinical trial of the use of sibutramine for the treatment of patients suffering essential obesity. Int J Obes Relat Metab Disord 2000; 24: 144\u2013150.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF0802887_CR23","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000047310","volume":"94","author":"BP Hazenberg","year":"2000","unstructured":"Hazenberg BP . Randomized, double-blind, placebo-controlled, multicenter study of sibutramine in obese hypertensive patients. Cardiology 2000; 94: 152\u2013158.","journal-title":"Cardiology"},{"key":"BF0802887_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/BF02850257","volume":"20","author":"G Fanghanel","year":"2003","unstructured":"Fanghanel G, Cortinas L, Sanchez-Reyes L, Gomez-Santos R, Campos-Franco E, Berber A . Safety and efficacy of sibutramine in overweight Hispanic patients with hypertension. Adv Ther 2003; 20: 101\u2013113.","journal-title":"Adv Ther"},{"key":"BF0802887_CR25","doi-asserted-by":"crossref","unstructured":"Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group. Arch Intern Med 1997; 157: 657\u2013667.","DOI":"10.1001\/archinte.157.6.657"},{"key":"BF0802887_CR26","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1056\/NEJM198602063140602","volume":"314","author":"SW MacMahon","year":"1986","unstructured":"MacMahon SW, Wilcken DE, Macdonald GJ . The effect of weight reduction on left ventricular mass. A randomized controlled trial in young, overweight hypertensive patients. N Engl J Med 1986; 314: 334\u2013339.","journal-title":"N Engl J Med"},{"key":"BF0802887_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJM197801052980101","volume":"298","author":"E Reisin","year":"1978","unstructured":"Reisin E, Abel R, Modan M, Silverberg DS, Eliahou HE, Modan B . Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N Engl J Med 1978; 298: 1\u20136.","journal-title":"N Engl J Med"},{"key":"BF0802887_CR28","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1161\/01.HYP.36.4.538","volume":"36","author":"G Grassi","year":"2000","unstructured":"Grassi G, Seravalle G, Dell'Oro R, Turri C, Bolla GB, Mancia G . Adrenergic and reflex abnormalities in obesity-related hypertension. Hypertension 2000; 36: 538\u2013542.","journal-title":"Hypertension"},{"issue":"Suppl 4","key":"BF0802887_CR29","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1038\/sj.ijo.0802218","volume":"26","author":"K Narkiewicz","year":"2002","unstructured":"Narkiewicz K . Sibutramine and its cardiovascular profile. Int J Obes Relat Metab Disord 2002; 26 (Suppl 4): S38\u2013S41.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF0802887_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/sj.jhh.1001299","volume":"16","author":"JJ Sramek","year":"2002","unstructured":"Sramek JJ, Leibowitz MT, Weinstein SP, Rowe ED, Mendel CM, Levy B, McMahon FG, Mullican WS, Toth PD, Cutler NR . Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial. J Hum Hypertens 2002; 16: 13\u201319.","journal-title":"J Hum Hypertens"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/0802887.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/0802887","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/0802887.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T07:33:11Z","timestamp":1684222391000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/0802887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2,1]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["BF0802887"],"URL":"https:\/\/doi.org\/10.1038\/sj.ijo.0802887","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2,1]]}}}